<p><strong>Vertex Pharmaceuticals Inc</strong>（紐約證券交易所代碼：VRTX）的空頭頭寸佔流通股的比例自上次報告以來上升了 11.24%。根據交易所報告的數據，目前有 <strong>446 萬股被賣空</strong>，這佔所有可交易普通股的 1.98%。根據其交易量，<strong>交易者平均需要 3.2 天來平倉他們的空頭頭寸。</strong></p>
<h3>為什麼空頭頭寸重要</h3>
<p>空頭頭寸是指已經被賣空但尚未平倉或關閉的股票數量。賣空 是指交易者出售他們並不擁有的公司的股票，希望價格下跌。如果股票價格下跌，交易者可以從賣空中獲利；如果價格上漲，他們則會虧損。</p>
<p>跟蹤空頭頭寸很重要，因為它可以作為市場對特定股票情緒的指標。空頭頭寸的增加可能表明投資者變得更加看跌，而空頭頭寸的減少則可能表明他們變得更加看漲。</p>
<p><strong>另見：</strong> 被賣空最多的股票列表</p>
<h3>Vertex Pharmaceuticals Inc 空頭頭寸圖表（3 個月）</h3>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765807234_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="short_fig" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765807234_0.png"/></p>
<p>從上面的圖表可以看出，Vertex Pharmaceuticals Inc 被賣空的股票比例自上次報告以來有所增長。這並不意味着該股票在短期內會下跌，但交易者應該意識到更多的股票正在被賣空。</p>
<h3>將 Vertex Pharmaceuticals Inc 的空頭頭寸與同行進行比較</h3>
<p>同行比較是分析師和投資者用來評估公司表現的一種流行技術。公司的同行是指在行業、規模、年齡和財務結構等方面具有相似特徵的其他公司。您可以通過閲讀公司的 10-K 報告、代理文件或進行自己的相似性分析來找到公司的同行羣體。</p>
<p>根據 Benzinga Pro，Vertex Pharmaceuticals Inc 的同行平均空頭頭寸佔流通股的比例為 7.41%，這意味着該公司的空頭頭寸 <strong>低於</strong> 大多數同行。</p>
<p>您知道空頭頭寸的增加實際上可能對股票是 <strong>看漲</strong> 的嗎？Benzinga Money 的這篇文章解釋了您如何從中獲利。</p>
<p><em>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</em></p>

福泰制藥

<p>Vertex Pharmaceuticals Inc 的空頭頭寸上升了 11.24%，短期賣出股票達到 446 萬股，佔可用股票的 1.98%。交易者需要 3.2 天來平倉這些頭寸。空頭頭寸的增加表明市場情緒偏向看跌，儘管 Vertex 的空頭頭寸相比同行較少。空頭頭寸可以反映市場情緒，並可能對股票產生看漲的影響</p>

<p><strong>Vertex Pharmaceuticals Inc's</strong> (NYSE: VRTX) short interest as a percent of float has risen 11.24% since its last report. According to exchange reported data, there are now <strong>4.46 million shares sold short</strong>, which is 1.98% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.2 days to cover their short positions on average.</strong></p>
<div class="lb-trans"><p><strong>Vertex Pharmaceuticals Inc</strong>（紐約證券交易所代碼：VRTX）的空頭頭寸佔流通股的比例自上次報告以來上升了 11.24%。根據交易所報告的數據，目前有 <strong>446 萬股被賣空</strong>，這佔所有可交易普通股的 1.98%。根據其交易量，<strong>交易者平均需要 3.2 天來平倉他們的空頭頭寸。</strong></p>
</div><h3>Why Short Interest Matters</h3>
<div class="lb-trans"><h3>為什麼空頭頭寸重要</h3>
</div><p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<div class="lb-trans"><p>空頭頭寸是指已經被賣空但尚未平倉或關閉的股票數量。賣空 是指交易者出售他們並不擁有的公司的股票，希望價格下跌。如果股票價格下跌，交易者可以從賣空中獲利；如果價格上漲，他們則會虧損。</p>
</div><p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<div class="lb-trans"><p>跟蹤空頭頭寸很重要，因為它可以作為市場對特定股票情緒的指標。空頭頭寸的增加可能表明投資者變得更加看跌，而空頭頭寸的減少則可能表明他們變得更加看漲。</p>
</div><p><strong>See Also:</strong> List of the most shorted stocks</p>
<div class="lb-trans"><p><strong>另見：</strong> 被賣空最多的股票列表</p>
</div><h3>Vertex Pharmaceuticals Inc Short Interest Graph (3 Months)</h3>
<div class="lb-trans"><h3>Vertex Pharmaceuticals Inc 空頭頭寸圖表（3 個月）</h3>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2025/1765807234_0.png" alt="short_fig" original-src="https://www.benzinga.com/files/images/story/2025/1765807234_0.png"/></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Vertex Pharmaceuticals Inc has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<div class="lb-trans"><p>從上面的圖表可以看出，Vertex Pharmaceuticals Inc 被賣空的股票比例自上次報告以來有所增長。這並不意味着該股票在短期內會下跌，但交易者應該意識到更多的股票正在被賣空。</p>
</div><h3>Comparing Vertex Pharmaceuticals Inc's Short Interest Against Its Peers</h3>
<div class="lb-trans"><h3>將 Vertex Pharmaceuticals Inc 的空頭頭寸與同行進行比較</h3>
</div><p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<div class="lb-trans"><p>同行比較是分析師和投資者用來評估公司表現的一種流行技術。公司的同行是指在行業、規模、年齡和財務結構等方面具有相似特徵的其他公司。您可以通過閲讀公司的 10-K 報告、代理文件或進行自己的相似性分析來找到公司的同行羣體。</p>
</div><p>According to Benzinga Pro, Vertex Pharmaceuticals Inc's peer group average for short interest as a percentage of float is 7.41%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<div class="lb-trans"><p>根據 Benzinga Pro，Vertex Pharmaceuticals Inc 的同行平均空頭頭寸佔流通股的比例為 7.41%，這意味着該公司的空頭頭寸 <strong>低於</strong> 大多數同行。</p>
</div><p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? This post by Benzinga Money explains how you can profit from it.</p>
<div class="lb-trans"><p>您知道空頭頭寸的增加實際上可能對股票是 <strong>看漲</strong> 的嗎？Benzinga Money 的這篇文章解釋了您如何從中獲利。</p>
</div><p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>
<div class="lb-trans"><p><em>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</em></p>
</div>

是什麼因素在推動 Vertex Pharmaceuticals Inc 的市場情緒？